In a prolonged subcutaneous tumour model (approximately 35 days), the inhibitory effect of anti-PD-1 monotherapy on tumour growth gradually decreased over time, whereas B-cell adoptive transfer restored tumour control, with further enhancement upon SENP7 knockdown in the transferred B cells (Fig. S9E-G). Here, SENP7 is linked to neoplasm.